Delivery Order SPE2DB20D1100-SPE2DB25FD5X5
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.72, is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S medical products. The contract has an ultimate completion date of March 7, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,045.24 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,074.02 to AmerisourceBergen Drug Corp on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's Corporate Office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award valued at $5,231.87 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price, non-set-aside delivery order is expected to be completed by July 29, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical supply vendor supporting federal healthcare procurement needs, particularly for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,171.48 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,423.41 to AmerisourceBergen Drug Corp on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The IDC, valued at $999.999 billion and extending through December 2026,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $7,240 delivery order to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract, designated as a non-competitive award with no set-aside provisions, represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5X5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Anucort-HC 25 mg suppositories (24-count packages) valued at $1,360.02. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999.99 million and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal vendor for military and veteran healthcare systems. The company's DLA IDC enables it to supply an extensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. As a child contract under the SPE2DX prime vehicle, this delivery order fulfills ongoing pharmaceutical supply requirements for the Defense Health Agency and other federal healthcare systems, demonstrating AmerisourceBergen's established capability to meet competitive federal procurement standards for critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/23/25 |